These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Current challenges in non-invasive insulin delivery systems: a comparative review. Khafagy el-S, Morishita M, Onuki Y, Takayama K. Adv Drug Deliv Rev; 2007 Dec 22; 59(15):1521-46. PubMed ID: 17881081 [Abstract] [Full Text] [Related]
10. New strategies to improve the intranasal absorption of insulin. Duan X, Mao S. Drug Discov Today; 2010 Jun 22; 15(11-12):416-27. PubMed ID: 20359545 [Abstract] [Full Text] [Related]
11. The pharmacokinetics of alternative insulin delivery systems. Strack T. Curr Opin Investig Drugs; 2010 Apr 22; 11(4):394-401. PubMed ID: 20336587 [Abstract] [Full Text] [Related]
13. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery. Zhang Y, Zhu J, Tang Y, Chen X, Yang Y. Drug Dev Ind Pharm; 2009 Sep 22; 35(9):1059-65. PubMed ID: 19640250 [Abstract] [Full Text] [Related]
19. Unlocking the opportunity of tight glycaemic control. Innovative delivery of insulin via the lung. Patton JS. Diabetes Obes Metab; 2005 Nov 30; 7 Suppl 1():S5-8. PubMed ID: 16135136 [Abstract] [Full Text] [Related]
20. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats. Wang J, Tabata Y, Morimoto K. J Control Release; 2006 Jun 12; 113(1):31-7. PubMed ID: 16707188 [Abstract] [Full Text] [Related] Page: [Next] [New Search]